These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

190 related items for PubMed ID: 2134714

  • 1. Combined antimonial allopurinol therapy in mucosal leishmaniasis.
    Sampaio RN, Marchán EM, Vexenat A, Tristão RJ, Marsden PD.
    Mem Inst Oswaldo Cruz; 1990; 85(3):373-4. PubMed ID: 2134714
    [No Abstract] [Full Text] [Related]

  • 2. Electrocardiographic alterations during treatment of mucocutaneous leishmaniasis with meglumine antimoniate and allopurinol.
    Antezana G, Zeballos R, Mendoza C, Lyevre P, Valda L, Cardenas F, Noriega I, Ugarte H, Dedet JP.
    Trans R Soc Trop Med Hyg; 1992; 86(1):31-3. PubMed ID: 1566297
    [Abstract] [Full Text] [Related]

  • 3. Mucosal leishmaniasis unresponsive to glucantime therapy successfully treated with AmBisome.
    Nonata R, Sampaio R, Marsden PD.
    Trans R Soc Trop Med Hyg; 1997; 91(1):77. PubMed ID: 9093636
    [No Abstract] [Full Text] [Related]

  • 4. Low dosage combination of meglumine antimoniate plus allopurinol as first choice treatment of infantile visceral leishmaniasis in Italy.
    di Martino L, Mantovani MP, Gradoni L, Gramiccia M, Guandalini S.
    Trans R Soc Trop Med Hyg; 1990; 84(4):534-5. PubMed ID: 2091347
    [No Abstract] [Full Text] [Related]

  • 5. The renal transplant patient with visceral leishmaniasis who could not tolerate meglumine antimoniate-cure with ketoconazole and allopurinol.
    Hueso M, Bover J, Serón D, Gil-Vernet S, Rufí G, Alsina J, Grinyó JM.
    Nephrol Dial Transplant; 1999 Dec; 14(12):2941-3. PubMed ID: 10570102
    [No Abstract] [Full Text] [Related]

  • 6. Effects of antimonial therapy for canine leishmaniasis on antibody titer.
    Amusategui I, Sainz A, Tesouro MA.
    Ann N Y Acad Sci; 1998 Jun 29; 849():444-6. PubMed ID: 9668509
    [No Abstract] [Full Text] [Related]

  • 7. Retention of antimony in hair during leishmaniasis treatment.
    Dorea JG, Merchan-Hamann E, Ryan DE, Holzbecher J.
    Clin Chim Acta; 1989 Feb 22; 179(3):341-5. PubMed ID: 2714007
    [No Abstract] [Full Text] [Related]

  • 8. [Miltefosine or meglumine antimoniate in leishmaniasis].
    Joob B, Wiwanitkit V.
    Medicina (B Aires); 2015 Feb 22; 75(2):130-1. PubMed ID: 25919881
    [No Abstract] [Full Text] [Related]

  • 9. [Miltefosine versus meglumine antimoniate in the treatment of mucosal leishmaniasis].
    Garcia Bustos MF, Barrio A, Parodi C, Beckar J, Moreno S, Basombrio MA.
    Medicina (B Aires); 2014 Feb 22; 74(5):371-7. PubMed ID: 25347898
    [Abstract] [Full Text] [Related]

  • 10. Assessment of allopurinol plus meglumine antimoniate in the treatment of visceral leishmaniasis in patients infected with HIV.
    Laguna F, López-Vélez R, Soriano V, Montilla P, Alvar J, González-Lahoz JM.
    J Infect; 1994 May 22; 28(3):255-9. PubMed ID: 8089514
    [Abstract] [Full Text] [Related]

  • 11. [Treatment of the mucosal form of leishmaniasis without response to glucantime, with liposomal amphotericin B].
    Sampaio RN, Marsden PD.
    Rev Soc Bras Med Trop; 1997 May 22; 30(2):125-8. PubMed ID: 9148335
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Evolution of serum albumin/globulin ratio after antimonial therapy in canine leishmaniasis.
    Amusategui I, Sainz A, Tesouro MA.
    Ann N Y Acad Sci; 1998 Jun 29; 849():447-9. PubMed ID: 9668510
    [No Abstract] [Full Text] [Related]

  • 14. [More about miltefosine in the treatment of mucosal leishmaniasis].
    Bustos MF, Barrio A, Basombrío MÁ.
    Medicina (B Aires); 2015 Jun 29; 75(2):131. PubMed ID: 25919882
    [No Abstract] [Full Text] [Related]

  • 15. Treatment of cutaneous leishmaniasis with a combination of allopurinol and low-dose meglumine antimoniate.
    Momeni AZ, Reiszadae MR, Aminjavaheri M.
    Int J Dermatol; 2002 Jul 29; 41(7):441-3. PubMed ID: 12121563
    [Abstract] [Full Text] [Related]

  • 16. Chemotherapy of leishmaniasis in India.
    Thakur CP.
    Indian J Pediatr; 1987 Jul 29; 54(1):7-10. PubMed ID: 3030933
    [No Abstract] [Full Text] [Related]

  • 17. Prevalence of mucocutaneous leishmaniasis in littoral Bahia, Brazil.
    Lago L, Vieira JB, Costa JL, Marsden PD.
    Trans R Soc Trop Med Hyg; 1990 Jul 29; 84(2):241. PubMed ID: 2389315
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Treatment of recurrent cutaneous Leishmaniasis.
    Momeni AZ, Aminjavaheri M.
    Int J Dermatol; 1995 Feb 29; 34(2):129-33. PubMed ID: 7737774
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.